药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Desomorphine
Bictegravir
The metabolism of Bictegravir can be decreased when combined with Pexidartinib.
Desomorphine
Raltegravir
The metabolism of Raltegravir can be decreased when combined with Pexidartinib.
Desomorphine
Gavestinel
The metabolism of Gavestinel can be decreased when combined with Pexidartinib.
Desomorphine
Muraglitazar
The metabolism of Muraglitazar can be decreased when combined with Pexidartinib.
Desomorphine
Bazedoxifene
The metabolism of Bazedoxifene can be decreased when combined with Pexidartinib.
Desomorphine
Migalastat
The metabolism of Migalastat can be decreased when combined with Pexidartinib.
Desomorphine
Ezogabine
The metabolism of Ezogabine can be decreased when combined with Pexidartinib.
Desomorphine
Belantamab mafodotin
The excretion of Belantamab mafodotin can be decreased when combined with Pexidartinib.
Desomorphine
Remdesivir
The excretion of Remdesivir can be decreased when combined with Pexidartinib.
Desomorphine
Levosalbutamol
The excretion of Levosalbutamol can be decreased when combined with Pexidartinib.
Desomorphine
Atrasentan
The excretion of Atrasentan can be decreased when combined with Pexidartinib.
Desomorphine
Propacetamol
The serum concentration of Propacetamol can be increased when it is combined with Pexidartinib.
Desomorphine
Metreleptin
The metabolism of Pexidartinib can be increased when combined with Metreleptin.
Desomorphine
Armodafinil
The metabolism of Pexidartinib can be increased when combined with Armodafinil.
Desomorphine
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Pexidartinib.
Desomorphine
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Pexidartinib.
5alpha-androstane-3alpha,17beta-diol
Gallium Ga-68 gozetotide
Darolutamide may increase effectiveness of Gallium Ga-68 gozetotide as a diagnostic agent.
5alpha-androstane-3alpha,17beta-diol
Satralizumab
The serum concentration of Darolutamide can be decreased when it is combined with Satralizumab.
5alpha-androstane-3alpha,17beta-diol
Abametapir
The serum concentration of Darolutamide can be increased when it is combined with Abametapir.
5alpha-androstane-3alpha,17beta-diol
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Darolutamide.